RXST vs STE · rev $139.9M vs P/E 25, rev $5.46B
Rxsight Inc (RXST) versus STERIS plc (STE) — a side-by-side from cached financials, not a winner call.
Rxsight Inc (RXST) is a medical devices company listed on NASDAQ.
STERIS plc (STE) is a medical devices company listed on NYSE.
Latest reported RXST revenue for 2024-12-31 was $139.9M. Net income was -$27.5M. Revenue was up 57.1% from 2023-12-31 to 2024-12-31. RXST currently screens at market cap $198.3M.
Latest reported STE revenue for 2025-03-31 was $5.46B. Net income was $616.1M. Revenue was up 284.6% from 2024-03-31 to 2025-03-31. STE currently screens at market cap $19.43B and trailing P/E 25.1.
RXST currently screens at market cap $198.3M. STE currently screens at market cap $19.43B and trailing P/E 25.1.
Not investment advice. Open the RXST and STE stock pages for the full models.
Not investment advice.